EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Predictive value of serum albumin levels on cancer survival: a prospective cohort study

Quan Tang, Xu Li, Chun-Rong Sun

Frontiers in Oncology · 04.03.2024 · 14

DOI: 10.3389/fonc.2024.1323192 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Oncology, online erschienen am 04.03.2024. Verfasst von Quan Tang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical …. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Serum albumin levels and cancer mortality are closely related, yet large-sample studies encompassing a broad spectrum of cancer types are lacking.

Methods

This study encompassed patients diagnosed with cancer across the continuous 10 cycles of NHANES surveys from 1999 to 2018. The study population was stratified into two groups based on median albumin levels (≤ 4.2g/dL and > 4.2 g/dL) or cancer aggressiveness (well-survived cancers and poorly-survived cancers). Survival rates were estimated using the Kaplan-Meier method. The Cox proportional hazards model was employed to evaluate the association between serum albumin levels and cancer mortality. Restricted cubic spline (RCS) analysis was conducted to assess the nonlinear relationship between serum albumin levels and the risk of cancer mortality.

Results

Kaplan-Meier curves demonstrated that patients with albumin levels ≤ 4.2 g/dL exhibited lower survival rates compared to those with levels > 4.2 g/dL, irrespective of cancer aggressiveness. Following adjustment for confounders, decreased albumin levels were associated with an elevated risk of cancer mortality across all groups [all cancers, HR (95%CI) = 2.03(1.73, 2.37); well survived cancers, HR (95%CI) = 1.78(1.38, 2.32); and poorly survived cancers, HR (95%CI) = 1.99(1.64, 2.42)]. RCS analyses revealed a stable nonlinear negative association between albumin levels and cancer mortality in all groups, regardless of confounder adjustment.

Conclusion

Low serum albumin levels predict higher cancer mortality. Furthermore, a nonlinear negative association was observed between serum albumin levels and the risk of cancer mortality.

Schlagwörter

Stichwörter der Autor:innen

National Health and Nutrition Examination Survey (NHANES)albumin levelscancer mortalitycardiovascular disease (CVD)restricted cubic spline (RCS)

Autor:innen und Institutionen

  • Department of General Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
  • Division of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Zitieren

APA

Tang, Q., Li, X., & Sun, C. R. (2024). Predictive value of serum albumin levels on cancer survival: a prospective cohort study. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1323192

Vancouver

Tang Q, Li X, Sun CR. Predictive value of serum albumin levels on cancer survival: a prospective cohort study. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1323192

BibTeX
@article{Tang2024,
  author = {Tang, Quan and Li, Xu and Sun, Chun-Rong},
  title = {Predictive value of serum albumin levels on cancer survival: a prospective cohort study},
  journal = {Frontiers in Oncology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fonc.2024.1323192}
}
Kostenlos starten →